Areas of Excellence
Each day millions of Americans struggle with painful and very often debilitating digestive disorders. Digestive diseases include such life-threatening illnesses as inflammatory bowel disease, gut and liver cancers, swallowing disorders or the daily discomfort of heartburn, diarrhea, constipation, dyspepsia and Crohn's Disease.
Digestive diseases have a major impact on health in the U.S. according to recent studies. More than 60 million digestive diseases are reported annually in the United States. The impact of digestive diseases on health in the United States includes 200 million days of restricted activity, 50 million visits to physicians, 10 million hospitalizations and 200,000 deaths according to a recent report from the National Institute of Health.
Most digestive disease can present a diagnostic challenge due to the lack of specific clinical symptoms or signs on physical examination. This may result in expensive and time-consuming diagnostic testing which may not yield answers. Consultation with a subspecialist experienced in gastrointestinal medicine may result in a successful explanation and direction towards treatment.
The overall goal of the Division of Gastroenterology and Hepatology is not only to provide state-of-the-art patient care but to advance the field of diagnosis and treatment of digestive diseases. Our Areas of Excellence pages give information on how innovative patient care and education is provided at the centers. They also illustrate the important role research plays in developing new and more effective treatments. We welcome your comments. Call us at (414) 955-6826 or e-mail us.
The Medical College of Wisconsin (MCW) Dysphagia Institute at Froedtert Hospital is a multi-disciplinary team committed to the diagnosis, research and treatment of patients with swallowing disorders. The Institute and its faculty have achieved international recognition for their basic and clinical research in swallowing disorders conducted over the last 30 years.
Inflammatory Bowel Disease Program
The IBD Program at Froedtert evaluates over 500 patients each year, making it the leading IBD program in southeastern Wisconsin. Dr. David Binion, Director of the IBD Program, notes, "Patients must understand that their involvement with the IBD Program encompasses so much more than just their care. What we learn from their experiences with IBD today will influence and improve future medical treatments."
The Pancreaticobiliary Center provides leading-edge capabilities in diagnosis and treatment of disorders of the pancreas and biliary tract. The multi-disciplinary team of experts includes therapeutic endoscopists, gastroenterologists, interventional and imaging radiologists, pancreaticobiliary and laparoscopic surgeons, medical and radiation oncologists, pathologists and motility experts who are experienced in providing the very latest technologies and procedures for treating patients with disorders of the pancreaticobiliary tract.
Hepatitis Treatment Program
The multidisciplinary program serving hepatitis patients strives to deliver expedient and exceptional quality of care at the highest possible level. Froedtert and the Medical College Transplant Teams have performed over 500 successful liver transplants, establishing themselves as a premier center for liver diseases and liver transplantation.
GI Cancer Surveillance Program
Each year, about 15,000 Americans find out they have esophageal cancer. The best chance for curing the disease is through early detection. In an attempt to screen those at risk, the GI Cancer Surveillance Center uses a new form of ultra-thin endoscopy.